Initial experience with extracorporeal membrane oxygenation following cardiac surgery in children with congenital heart disease

Sharma, Anshu; Pokharel, Jeju Nath; Upreti, Murari Raj; Koirala, Bhagawan; Sharma, Jyotindra; Pradhan, Sidharth; Bhatta, Mahendra

doi:10.3126/njh.v11i1.10980

Cited by 3 publications

(1 citation statement)

References 20 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Extracorporeal Membrane Oxygenator (ECMO) was used in cardiac surgical patients for the first time in 9 th September, 2009 in Shahid Gangalal Heart Center. 7 Cardiac anesthesia service now is being provided not only in teaching institutes and private hospitals of Kathmandu valley but has also extended outside valley in few institutes.…”

Section: Journal Of Society Of Anesthesiologists Of Nepalmentioning

confidence: 99%

Moonwalk in Cardiac anesthesia platform in Nepal

Pradhan¹

2019

J. Soc. Anesth. Nep.

View full text Add to dashboard Cite

show abstract

Section: Journal Of Society Of Anesthesiologists Of Nepalmentioning

confidence: 99%

Moonwalk in Cardiac anesthesia platform in Nepal

Pradhan¹

2019

J. Soc. Anesth. Nep.

View full text Add to dashboard Cite

show abstract

Cardiovascular Anesthesia and Critical Care Services in the Federal Democratic Republic of Nepal

Amatya

Bajracharya

Acharya

et al. 2017

Journal of Cardiothoracic and Vascular Anesthesia

View full text Add to dashboard Cite

Extracorporeal membrane oxygenation in aluminum phosphide poisoning in Nepal: a case report

Sharma¹,

Sharma²,

Acharya³

et al. 2018

J Med Case Reports

Self Cite

View full text Add to dashboard Cite

BackgroundAluminum phosphide is a very common suicide agent in developing countries like Nepal. Due to the unavailability of a specific antidote, mortality is very high because the phosphine molecule that is formed leads to inhibition of the cytochrome oxidase enzyme system in mitochondria. Extracorporeal membrane oxygenation provides life-saving support to the cardiovascular and respiratory systems until the deadly poison is eliminated from the body.Case presentationWe encountered one case of 67-year-old Asian woman, a known case of major depressive disorder, who presented to our center with suicidal ingestion of aluminum phosphide with cardiovascular and respiratory dysfunction. On presentation in our emergency room, she had an ejection fraction of 20% and had to be immediately intubated for respiratory failure. Based on the evidence of almost 100% mortality with aluminum phosphide poisoning, extracorporeal membrane oxygenation was initiated in our intensive care unit. Her general condition and hemodynamics gradually improved over the course of 2 days and she was weaned from extracorporeal membrane oxygenation and ventilator by post-extracorporeal membrane oxygenation days 3 and 4, respectively. After psychiatric evaluation and establishment of normal vital parameters, she was moved out of intensive care unit on post-extracorporeal membrane oxygenation day 6 and discharged to home on post-extracorporeal membrane oxygenation day 10.ConclusionsAlthough this seems to be a small step in terms of global perspective, it is a giant stride for a developing country. The management of reversible but severe cardiac and respiratory failure certainly opens up newer scopes where we can ensure a quality health care service being made accessible even to the most underprivileged people.

show abstract

Initial experience with extracorporeal membrane oxygenation following cardiac surgery in children with congenital heart disease

Cited by 3 publications

References 20 publications

Moonwalk in Cardiac anesthesia platform in Nepal

Moonwalk in Cardiac anesthesia platform in Nepal

Cardiovascular Anesthesia and Critical Care Services in the Federal Democratic Republic of Nepal

Extracorporeal membrane oxygenation in aluminum phosphide poisoning in Nepal: a case report

Contact Info

Product

Resources

About